Navigation Links
UIC joins international research effort to study autism
Date:11/14/2008

Researchers at the University of Illinois at Chicago are taking part in an international effort to gather DNA samples from 2,000 autism patients and their families over the next three years.

The initiative, called the Simons Simplex Collection, is the first coordinated effort to create a database of information about families with only one autistic child.

"This collection of DNA will allow researchers at UIC and at other centers to identify genetic factors that increase the risk of autism and to potentially develop interventional therapies and new drugs for the treatment of autism spectrum disorders," said Dr. Edwin Cook, professor of psychiatry, director of the UIC Autism Center of Excellence, and principal investigator of the study.

Autism is an often devastating and lifelong disorder that appears during the first three years of life. Children and adults with autism often have difficulty communicating and forming relationships. The variation of behaviors and level of functioning among people with autism differ greatly.

The national Centers for Disease Control and Prevention estimates that about one of every 150 eight-year-old children is diagnosed with some form of autism spectrum disorder. Autism spectrum disorders occur in all populations and socioeconomic groups and are four times more likely to occur in boys than in girls.

Families eligible to participate in the study include those with only one child with an autism spectrum disorder, age four or older; one or more siblings without an autism spectrum disorder, age four or older; and unaffected biological parents who are willing to participate.

Eligible children with an autism spectrum disorder will receive a behavioral assessment and all family members will donate blood, a source of DNA. A small number of families with no siblings or siblings under the age of four may be eligible to participate in the study.

DNA gathered through the Simons Sim
'/>"/>

Contact: Sherri McGinnis Gonzlez
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Former NBA and Boston Celtic Star Dee Brown Joins PrimeTime Sports, Boca Ratons Unique Sports Training Facility
2. Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance
3. Trust for Americas Health Joins GAO in Calling for Next Administration to Focus on Urgent Public Health Issues as Top Priorities
4. Diabetes Dad Tom Karlya Rejoins Diabetes Research Institute Foundation
5. Groseth Rejoins EMSI to Lead Healthcare Services Sales
6. Healthy Eating Expert Ellie Krieger Joins Yoplait(R) Yo-Plus(TM) to Raise Awareness of Digestive Health
7. EarthSearch Communications International Joins Motorola's Enterprise Mobility Business PartnerSelect Program
8. AmerisourceBergen Joins National Patient Safety Foundation Corporate Council
9. Cargill Executive Joins Blue Cross Board of Trustees
10. Norm Botsford Joins Culbert Healthcare Solutions Strategic Services Team
11. New Chief Executive Officer Joins International Diabetes Federation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...YNE, Pa., Nov. 30 Vitami...ND) has elected William "Bill" R. Fields to the B...e 59, is Chairman of Intersource Co. Ltd. Mr. Fiel...eviously, Mr. Fields served as Chairman and Chief ... 2002 to 2003, President and Chief Executive Offic...
(Date:11/30/2009)...GTON, Nov. 30 At a brie...ons (LCAO) and the Consortium for Citizens with Di...ent of Public Policy and Advocacy for NCOA, called...islation responds to the growing crisis in long-te..., "Millions of seniors, after working hard all t...
(Date:11/30/2009)...O, Nov. 30 /PRNewswire-FirstCall/ - AIM Health Gro...ully integrated health care company, announced tod...ended September 30, 2009 (the "Quarter") increased...08. At the same time EBITDA(1) increased 290% to $...asis. The Company also announced that revenues inc...
(Date:11/30/2009)...TLE, Nov. 30 Major League Baseba...ansas City Royals and recently acquired by the Chi...®). The award is given annually to a Major Le...r, courage and dedication of baseball great Fred H... 28-year-old Redlands, Calif., native made his MLB...
(Date:11/30/2009)... Nov. 30 I,m surprised and dismaye...ek. At every step of my life and my career as an ...ndent Ombudsman for the Texas Youth Commission, I ... My professional commitment to the protection, pre... my personal passion. ,, Of the many concerns...
Breaking Medicine News(10 mins):Health News:VitaminSpice Elects Bill Fields to the Board of Directors 2Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:Independent Ombudsman for Texas Youth Commission Resigns 2
...porosis Foundation (NOF) will honor two-time Acade...ly Field; local D.C. celebrities and owners of FLE...d chairman of EmpowHer, Michelle King Robson, at i...ce of Bel-Air" will serve as mistress of ceremonie...
...honors the accomplishments of medical education pr...ouston, TX (PRWEB) May 20, 2009 -- TIAA-CREF, a n...rovider of retirement services in the academic, me...Award ( www.tiaa-crefaward.org ). , , , , ,The TI...
...ess Ten Years After Institute of Medicine Found Up..., Texas, May 20 Ten years ago, the Institute of M...ad toll of medical errors in a groundbreaking repo...shed, little progress has been made implementing k...
...ration (Nasdaq: MDTH ) will host a conference ca...uss results from its second quarter ended March 31...ouncing those results and file its Form 10-Q with ...: 10:00 a.m ET, Friday, May 22, 2009, ...
...s, Inc. (Nasdaq: VSCP ), a leading provider of q...ounced that it has received notification from The ...e with the minimum $1.00 per share bid price requi...ce rule, the Company was required to evidence a cl...
...versity of California, San Francisco and Baystate ...s concludes that patients facing coronary artery b...a medical facility that has the highest adherence ...nces in quality of care might influence outcomes f...
Other Medicine News:Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 2Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 3Health News:Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness 4Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 2Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 3Health News:Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 2Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 3Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 4Health News:U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors 5Health News:MedCath Corporation to Hold Conference Call on Second Quarter Results 2Health News:VirtualScopics Regains NASDAQ Compliance 2Health News:Quality measures improve outcomes more than hospital volume alone 2Health News:Quality measures improve outcomes more than hospital volume alone 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Decub... Review ,, http://www.reportlinker.com/p01642...e-Market-Review.html ,, Decubitus Ulcers are ...stant pressure of the patient,s bodyweight. Pressu...
(Date:11/30/2009)... , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswire/ -...e completion of a Phase I study of CPSI-2364, its ...duction of TNF-alpha and other pro-inflammatory cy...ose escalation study in healthy volunteers confirm...esting. ,, All 30 enrolled subjects completed...
(Date:11/30/2009)..., CHICAGO, Nov. 30 Dr. Jocelyn R...Intervention at George Washington University Medic...cult lesions identified with Breast-Specific Gamma...odality imaging for needle biopsy as well, as for ...ting of the Radiological Society of North America ...
Breaking Medicine Technology:Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 2Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 3Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 4Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 5Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review 6Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 1Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 2Korein Tillery 3A Is Time Running Out for the Manufacturers of the Herbicide Atrazine 3F 55156 3Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 1Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 2Kaiser Permanente Named 2009 Company of the Year by LATINA Style Magazine 55154 3NIAID to fund new human immune profiling research centers 55152 1NIAID to fund new human immune profiling research centers 55152 2
...(TM) is evaluating zonisamide SR as a novel compon...EGO, June 07, 2007 /PRNewswire-FirstCall/ -- Orexi...ompany focused on the,treatment of central nervous..., today announced results from a Phase I trial eva...proprietary,sustained-release (SR) formulation of...
...ITY, Calif.--(BUSINESS WIRE)--Jun 6, 2007 - Gilead... Study 102, a,Phase III clinical trial evaluating ...ofovir disoproxil fumarate or tenofovir,DF) 300 mg...virus,(HBV) infection, met its primary efficacy en...r to the company,s once-daily antiviral,drug Hepse...
Other Medicine Technology:OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
Atria 6100
VASOVIEW® HemoPro™ Endoscopic Vessel Harvesting System
PM-9000 Express Patient Monitor
BC-3200 Auto Hematology Analyzer
Medicine Products: